RARRES2 and inflammatory bowel disease: By pooling data from recent observational studies and conducting rigorous subgroup and sensitivity analyses, this study aims to clarify chemerin’s role as a potential non-invasive biomarker for IBD diagnosis and monitoring, thereby addressing an important gap in the literature.